NCT00048204View on ClinicalTrials.gov

A Study Of A New Medicine (GW597599B) For The Treatment Of Major Depressive Disorder

PHASE2CompletedINTERVENTIONAL

Enrollment

372

Participants

Timeline

Start Date

November 4, 2002

Primary Completion Date

September 30, 2003

Study Completion Date

September 30, 2003

Conditions

Depressive Disorder, Major

Interventions

DRUG

GW597599B

DRUG

paroxetine

Sponsors

Lead Sponsor

GlaxoSmithKline

All Listed Sponsors

lead

GlaxoSmithKline

INDUSTRY